Advertisement

Index by author

November 01, 1990; Volume 255,Issue 2

A

  1. Abbate, G M

    1. Selective 5-hydroxytryptamine2 receptor antagonists protect against the neurotoxicity of methylenedioxymethamphetamine in rats.
      C J Schmidt, G M Abbate, C K Black and V L Taylor
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 478-483;

  2. Abid, S

    1. Protection against gentamicin-induced early renal alterations (phospholipidosis and increased DNA synthesis) by coadministration of poly-L-aspartic acid.
      D Beauchamp, G Laurent, P Maldague, S Abid, B K Kishore and P M Tulkens
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 858-866;

  3. Abiko, Y

    1. Both d-cis- and l-cis-diltiazem have anti-ischemic action in the isolated, perfused working rat heart.
      Y Nasa, K Ichihara and Y Abiko
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 680-689;

  4. Adams, M L

    1. Influence of chronic alcohol administration on representative indices of puberty and sexual maturation in male rats and the development of their progeny.
      T J Cicero, M L Adams, L O'Connor, B Nock, E R Meyer and D Wozniak
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 707-715;

  5. Aharony, D

    1. Modulation of ligand binding to leukotriene B4 receptors on guinea pig lung membranes by sulfhydryl modifying reagents.
      R C Falcone and D Aharony
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 565-571;

  6. Ahtee, L

    1. Augmentation of morphine-induced changes in brain monoamine metabolism after chronic naltrexone treatment.
      L Ahtee, L M Attila and K R Carlson
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 803-808;

  7. Alvarez, C

    1. Naloxone potentiation of cardiovascular responses to sympathomimetic amines in the rat.
      M Feria, C Alvarez, J Domínguez, A Sánchez and J Boada
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 523-528;

  8. Alzheimer, C

    1. Nonopioid actions of the kappa-opioid receptor agonists, U 50488H and U 69593 on electrophysiologic properties of hippocampal CA3 neurons in vitro.
      C Alzheimer and G ten Bruggencate
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 900-905;

  9. Appel, N M

    1. Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain.
      N M Appel, W M Mitchell, R K Garlick, R A Glennon, M Teitler and E B De Souza
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 843-857;

  10. Ardecky, R J

    1. Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2).
      P C Wong, S D Hart, A M Zaspel, A T Chiu, R J Ardecky, R D Smith and P B Timmermans
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 584-592;

  11. Armario, A

    1. On the metallothionein, glutathione and cysteine relationship in rat liver.
      J Hidalgo, J S Garvey and A Armario
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 554-564;

  12. Asano, M

    1. Possible involvement of ATP-sensitive K+ channels in the relaxant response of dog middle cerebral artery to cromakalim.
      K Masuzawa, M Asano, T Matsuda, Y Imaizumi and M Watanabe
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 818-825;

  13. Attila, L M

    1. Augmentation of morphine-induced changes in brain monoamine metabolism after chronic naltrexone treatment.
      L Ahtee, L M Attila and K R Carlson
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 803-808;

B

  1. Baizman, E

    1. Pharmacology of pravadoline: a new analgesic agent.
      D R Haubrich, S J Ward, E Baizman, M R Bell, J Bradford, R Ferrari, M Miller, M Perrone, A K Pierson and J K Saelens
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 511-522;

  2. Beauchamp, D

    1. Protection against gentamicin-induced early renal alterations (phospholipidosis and increased DNA synthesis) by coadministration of poly-L-aspartic acid.
      D Beauchamp, G Laurent, P Maldague, S Abid, B K Kishore and P M Tulkens
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 858-866;

  3. Beaufort, P

    1. SR 33557, a novel calcium entry blocker. II. Interactions with 1,4-dihydropyridine, phenylalkylamine and benzothiazepine binding sites in rat heart sarcolemmal membranes.
      P Nokin, M Clinet, P Beaufort, L Meysmans, R Laruel and P Chatelain
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 600-607;

  4. Bell, M R

    1. Pharmacology of pravadoline: a new analgesic agent.
      D R Haubrich, S J Ward, E Baizman, M R Bell, J Bradford, R Ferrari, M Miller, M Perrone, A K Pierson and J K Saelens
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 511-522;

  5. Berdeaux, A

    1. Effects of cromakalim and pinacidil on large epicardial and small coronary arteries in conscious dogs.
      J F Giudicelli, C D la Rochelle and A Berdeaux
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 836-842;

  6. Berson, A

    1. Stereoselective and nonstereoselective effects of ibuprofen enantiomers on mitochondrial beta-oxidation of fatty acids.
      E Freneaux, B Fromenty, A Berson, G Labbe, C Degott, P Letteron, D Larrey and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 529-535;

  7. Bidani, A

    1. Dipyridamole inhibition of HCO3(-)-Cl- exchange in human erythrocytes.
      T A Heming, C G Vanoye and A Bidani
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 631-635;

  8. Black, C K

    1. Selective 5-hydroxytryptamine2 receptor antagonists protect against the neurotoxicity of methylenedioxymethamphetamine in rats.
      C J Schmidt, G M Abbate, C K Black and V L Taylor
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 478-483;

  9. Blasberg, R G

    1. Kinetic analysis of the opiate antagonist cyclofoxy in rat brain: simultaneous infusion of active and inactive enantiomers.
      R Kawai, Y Sawada, M Channing, B Dunn, A H Newman, K C Rice and R G Blasberg
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 826-835;

  10. Bleasdale, J E

    1. Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils.
      J E Bleasdale, N R Thakur, R S Gremban, G L Bundy, F A Fitzpatrick, R J Smith and S Bunting
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 756-768;

  11. Blumberg, P M

    1. Resiniferatoxin: an ultrapotent selective modulator of capsaicin-sensitive primary afferent neurons.
      J Szolcsanyi, A Szallasi, Z Szallasi, F Joo and P M Blumberg
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 923-928;

  12. Boada, J

    1. Naloxone potentiation of cardiovascular responses to sympathomimetic amines in the rat.
      M Feria, C Alvarez, J Domínguez, A Sánchez and J Boada
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 523-528;

  13. Boughattas, N A

    1. Stable circadian mechanisms of toxicity of two platinum analogs (cisplatin and carboplatin) despite repeated dosages in mice.
      N A Boughattas, F Lévi, C Fournier, B Hecquet, G Lemaigre, A Roulon, G Mathé and A Reinberg
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 672-679;

  14. Bourguignon, J J

    1. A specific gamma-hydroxybutyrate receptor ligand possesses both antagonistic and anticonvulsant properties.
      M Maitre, V Hechler, P Vayer, S Gobaille, C D Cash, M Schmitt and J J Bourguignon
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 657-663;

  15. Bowen, W D

    1. Opioid agonist and antagonist antinociceptive properties of [D-Ala2,Leu5,Cys6]enkephalin: selective actions at the deltanoncomplexed site.
      J A Qi, W D Bowen, H I Mosberg, R B Rothman and F Porreca
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 636-641;

  16. Bradford, J

    1. Pharmacology of pravadoline: a new analgesic agent.
      D R Haubrich, S J Ward, E Baizman, M R Bell, J Bradford, R Ferrari, M Miller, M Perrone, A K Pierson and J K Saelens
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 511-522;

  17. Breslow, R

    1. Evidence that peptidoleukotriene is a prerequisite for antigen-dependent thromboxane synthesis in IgG1-passively sensitized guinea pig lungs.
      J B Cheng, J S Pillar, M J Conklyn, R Breslow, J T Shirley and H J Showell
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 664-671;

  18. Brown, J

    1. Augmentation of release of gastric somatostatin-like immunoreactivity by adenosine, adenosine triphosphate and their analogs.
      Y N Kwok, C McIntosh and J Brown
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 781-788;

  19. Bryant, H U

    1. Suppressive effects of morphine pellet implants on in vivo parameters of immune function.
      H U Bryant and R E Roudebush
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 410-414;

  20. Buciak, J

    1. Evaluation of cationized rat albumin as a potential blood-brain barrier drug transport vector.
      W M Pardridge, D Triguero, J Buciak and J Yang
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 893-899;

  21. Bundy, G L

    1. Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils.
      J E Bleasdale, N R Thakur, R S Gremban, G L Bundy, F A Fitzpatrick, R J Smith and S Bunting
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 756-768;

  22. Bunting, S

    1. Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils.
      J E Bleasdale, N R Thakur, R S Gremban, G L Bundy, F A Fitzpatrick, R J Smith and S Bunting
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 756-768;

  23. Bush, L G

    1. Neurotensin-dopamine interactions in the substantia nigra of the rat brain.
      K M Merchant, L G Bush, J W Gibb and G R Hanson
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 775-780;

  24. Buxton, I L

    1. On the ability of endogenous adenosine to regulate purine nucleoside receptor binding of antagonists in smooth muscle membranes.
      W P Schiemann, J M Walther and I L Buxton
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 886-892;

C

  1. Carlson, K R

    1. Augmentation of morphine-induced changes in brain monoamine metabolism after chronic naltrexone treatment.
      L Ahtee, L M Attila and K R Carlson
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 803-808;

  2. Cash, C D

    1. A specific gamma-hydroxybutyrate receptor ligand possesses both antagonistic and anticonvulsant properties.
      M Maitre, V Hechler, P Vayer, S Gobaille, C D Cash, M Schmitt and J J Bourguignon
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 657-663;

  3. Chang, L H

    1. Opiate-receptor antagonist improves metabolic recovery and limits neurochemical alterations associated with reperfusion after global brain ischemia in rats.
      A I Faden, R Shirane, L H Chang, T L James, M Lemke and P R Weinstein
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 451-458;

  4. Chang, P C

    1. Fate of tritiated 6-fluorodopamine in rats: a false neurotransmitter for positron emission tomographic imaging of sympathetic innervation and function.
      P C Chang, K Szemeredi, E Grossman, I J Kopin and D S Goldstein
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 809-817;

  5. Channing, M

    1. Kinetic analysis of the opiate antagonist cyclofoxy in rat brain: simultaneous infusion of active and inactive enantiomers.
      R Kawai, Y Sawada, M Channing, B Dunn, A H Newman, K C Rice and R G Blasberg
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 826-835;

  6. Charette, L

    1. Selective inhibition of relaxation of guinea-pig trachea by charybdotoxin, a potent Ca(++)-activated K+ channel inhibitor.
      T R Jones, L Charette, M L Garcia and G J Kaczorowski
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 697-706;

  7. Chatelain, P

    1. SR 33557, a novel calcium entry blocker. I. In vitro isolated tissue studies.
      P Polster, B Christophe, M Van Damme, A Houlliche and P Chatelain
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 593-599;
    2. SR 33557, a novel calcium entry blocker. II. Interactions with 1,4-dihydropyridine, phenylalkylamine and benzothiazepine binding sites in rat heart sarcolemmal membranes.
      P Nokin, M Clinet, P Beaufort, L Meysmans, R Laruel and P Chatelain
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 600-607;

  8. Cheng, J B

    1. Evidence that peptidoleukotriene is a prerequisite for antigen-dependent thromboxane synthesis in IgG1-passively sensitized guinea pig lungs.
      J B Cheng, J S Pillar, M J Conklyn, R Breslow, J T Shirley and H J Showell
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 664-671;

  9. Chiu, A T

    1. Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2).
      P C Wong, S D Hart, A M Zaspel, A T Chiu, R J Ardecky, R D Smith and P B Timmermans
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 584-592;

  10. Christophe, B

    1. SR 33557, a novel calcium entry blocker. I. In vitro isolated tissue studies.
      P Polster, B Christophe, M Van Damme, A Houlliche and P Chatelain
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 593-599;

  11. Cicero, T J

    1. Antagonist-induced up-regulation of the putative epsilon opioid receptor in rat brain: comparison with kappa, mu and delta opioid receptors.
      A L Giordano, B Nock and T J Cicero
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 536-540;
    2. Influence of chronic alcohol administration on representative indices of puberty and sexual maturation in male rats and the development of their progeny.
      T J Cicero, M L Adams, L O'Connor, B Nock, E R Meyer and D Wozniak
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 707-715;

  12. Clarke, W P

    1. Functional interactions in smooth muscle: kinetic characterization of the relaxation and desensitization responses to a beta adrenergic agonist in the rabbit aorta.
      S A Keitz, R Osman, W P Clarke, J Goldfarb and S Maayani
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 650-656;

  13. Clinet, M

    1. SR 33557, a novel calcium entry blocker. II. Interactions with 1,4-dihydropyridine, phenylalkylamine and benzothiazepine binding sites in rat heart sarcolemmal membranes.
      P Nokin, M Clinet, P Beaufort, L Meysmans, R Laruel and P Chatelain
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 600-607;

  14. Compton, D R

    1. Characterization of the lipophilicity of natural and synthetic analogs of delta 9-tetrahydrocannabinol and its relationship to pharmacological potency.
      B F Thomas, D R Compton and B R Martin
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 624-630;

  15. Conklyn, M J

    1. Evidence that peptidoleukotriene is a prerequisite for antigen-dependent thromboxane synthesis in IgG1-passively sensitized guinea pig lungs.
      J B Cheng, J S Pillar, M J Conklyn, R Breslow, J T Shirley and H J Showell
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 664-671;

  16. Cox, P G

    1. Renal disposition and effects of naproxen and its l-enantiomer in the isolated perfused rat kidney.
      P G Cox, W M Moons, F G Russel and C A van Ginneken
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 491-496;

D

  1. Danielou, G

    1. The activity of zolpidem and other hypnotics within the gamma-aminobutyric acid (GABAA) receptor supramolecular complex, as determined by 35S-t-butylbicyclophosphorothionate (35S-TBPS) binding to rat cerebral cortex membranes.
      G K Lloyd, G Danielou and F Thuret
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 690-696;

  2. DeCoursey, T E

    1. Mechanisms of potassium channel block in rat alveolar epithelial cells.
      E R Jacobs and T E DeCoursey
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 459-472;

  3. Degott, C

    1. Stereoselective and nonstereoselective effects of ibuprofen enantiomers on mitochondrial beta-oxidation of fatty acids.
      E Freneaux, B Fromenty, A Berson, G Labbe, C Degott, P Letteron, D Larrey and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 529-535;

  4. Descamps-Latscha, B

    1. In vivo treatment with benzodiazepines inhibits murine phagocyte oxidative metabolism and production of interleukin 1, tumor necrosis factor and interleukin-6.
      F Zavala, V Taupin and B Descamps-Latscha
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 442-450;

  5. De Souza, E B

    1. Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain.
      N M Appel, W M Mitchell, R K Garlick, R A Glennon, M Teitler and E B De Souza
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 843-857;

  6. Djuric, S W

    1. Effect of the leukotriene B4 receptor antagonist SC-41930 on colonic inflammation in rat, guinea pig and rabbit.
      D J Fretland, D Widomski, B S Tsai, J M Zemaitis, S Levin, S W Djuric, R L Shone and T S Gaginella
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 572-576;

  7. Domínguez, J

    1. Naloxone potentiation of cardiovascular responses to sympathomimetic amines in the rat.
      M Feria, C Alvarez, J Domínguez, A Sánchez and J Boada
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 523-528;

  8. Dominiak, P

    1. Levodopa delivery from controlled-release polymer matrix: delivery of more than 600 days in vitro and 225 days of elevated plasma levels after subcutaneous implantation in rats.
      B A Sabel, P Dominiak, W Häuser, M J During and A Freese
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 914-922;

  9. Drewett, J G

    1. Neuromodulatory effects of atrial natriuretic factor are independent of guanylate cyclase in adrenergic neuronal pheochromocytoma cells.
      J G Drewett, R J Ziegler and G J Trachte
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 497-503;

  10. Dunn, B

    1. Kinetic analysis of the opiate antagonist cyclofoxy in rat brain: simultaneous infusion of active and inactive enantiomers.
      R Kawai, Y Sawada, M Channing, B Dunn, A H Newman, K C Rice and R G Blasberg
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 826-835;

  11. During, M J

    1. Levodopa delivery from controlled-release polymer matrix: delivery of more than 600 days in vitro and 225 days of elevated plasma levels after subcutaneous implantation in rats.
      B A Sabel, P Dominiak, W Häuser, M J During and A Freese
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 914-922;

E

  1. Echizen, H

    1. Pharmacodynamic characterization of posture-related diuretic and saluretic responses to furosemide in humans.
      T Okaniwa, H Echizen, T Ishizaki, M Kasao and T Iizuka
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 716-723;

F

  1. Faden, A I

    1. Opiate-receptor antagonist improves metabolic recovery and limits neurochemical alterations associated with reperfusion after global brain ischemia in rats.
      A I Faden, R Shirane, L H Chang, T L James, M Lemke and P R Weinstein
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 451-458;
    2. Effects of TRH-analog treatment on tissue cations, phospholipids and energy metabolism after spinal cord injury.
      A I Faden, S W Yum, M Lemke and R Vink
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 608-614;

  2. Falcone, R C

    1. Modulation of ligand binding to leukotriene B4 receptors on guinea pig lung membranes by sulfhydryl modifying reagents.
      R C Falcone and D Aharony
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 565-571;

  3. Farhat, M Y

    1. Endothelium-mediated effects of N-substituted arginines on the isolated perfused rat kidney.
      M Y Farhat, P W Ramwell and G Thomas
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 473-477;

  4. Feria, M

    1. Naloxone potentiation of cardiovascular responses to sympathomimetic amines in the rat.
      M Feria, C Alvarez, J Domínguez, A Sánchez and J Boada
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 523-528;

  5. Ferrari, R

    1. Pharmacology of pravadoline: a new analgesic agent.
      D R Haubrich, S J Ward, E Baizman, M R Bell, J Bradford, R Ferrari, M Miller, M Perrone, A K Pierson and J K Saelens
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 511-522;

  6. Fitzpatrick, F A

    1. Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils.
      J E Bleasdale, N R Thakur, R S Gremban, G L Bundy, F A Fitzpatrick, R J Smith and S Bunting
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 756-768;

  7. Fournier, C

    1. Stable circadian mechanisms of toxicity of two platinum analogs (cisplatin and carboplatin) despite repeated dosages in mice.
      N A Boughattas, F Lévi, C Fournier, B Hecquet, G Lemaigre, A Roulon, G Mathé and A Reinberg
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 672-679;

  8. Franklin, M R

    1. Effect of aging on hepatic biotransformation in female Fischer 344 rats: changes in sulfotransferase activities are consistent with known gender-related changes in pituitary growth hormone secretion in aging animals.
      R E Galinsky, D H Johnson, R E Kane and M R Franklin
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 577-583;

  9. Freese, A

    1. Levodopa delivery from controlled-release polymer matrix: delivery of more than 600 days in vitro and 225 days of elevated plasma levels after subcutaneous implantation in rats.
      B A Sabel, P Dominiak, W Häuser, M J During and A Freese
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 914-922;

  10. Freneaux, E

    1. Stereoselective and nonstereoselective effects of ibuprofen enantiomers on mitochondrial beta-oxidation of fatty acids.
      E Freneaux, B Fromenty, A Berson, G Labbe, C Degott, P Letteron, D Larrey and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 529-535;

  11. Fretland, D J

    1. Effect of the leukotriene B4 receptor antagonist SC-41930 on colonic inflammation in rat, guinea pig and rabbit.
      D J Fretland, D Widomski, B S Tsai, J M Zemaitis, S Levin, S W Djuric, R L Shone and T S Gaginella
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 572-576;

  12. Frey, H H

    1. Pharmacokinetics, anticonvulsant efficacy and adverse effects of the beta-carboline abecarnil, a novel ligand for benzodiazepine receptors, after acute and chronic administration in dogs.
      W Löscher, D Hönack, R Scherkl, A Hashem and H H Frey
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 541-548;

  13. Fromenty, B

    1. Stereoselective and nonstereoselective effects of ibuprofen enantiomers on mitochondrial beta-oxidation of fatty acids.
      E Freneaux, B Fromenty, A Berson, G Labbe, C Degott, P Letteron, D Larrey and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 529-535;

  14. Funck-Brentano, C

    1. Genetically determined steady-state interaction between encainide and quinidine in patients with arrhythmias.
      J Turgeon, H N Pavlou, W Wong, C Funck-Brentano and D M Roden
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 642-649;

G

  1. Gaginella, T S

    1. Effect of the leukotriene B4 receptor antagonist SC-41930 on colonic inflammation in rat, guinea pig and rabbit.
      D J Fretland, D Widomski, B S Tsai, J M Zemaitis, S Levin, S W Djuric, R L Shone and T S Gaginella
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 572-576;

  2. Galinsky, R E

    1. Effect of aging on hepatic biotransformation in female Fischer 344 rats: changes in sulfotransferase activities are consistent with known gender-related changes in pituitary growth hormone secretion in aging animals.
      R E Galinsky, D H Johnson, R E Kane and M R Franklin
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 577-583;

  3. Gang, Y A

    1. Cimetidine transport in isolated brush border membrane vesicles from bovine choroid plexus.
      M T Whittico, Y A Gang and K M Giacomini
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 615-623;

  4. Garay, R P

    1. CRE 10904 [2-(p-fluorophenoxy), 1-(o-hydroxyphenyl)-ethane]: a new diuretic and antihypertensive drug acting by in vivo sulfation.
      R P Garay, J P Labaune, D Mesangeau, C Nazaret, T Imbert and G Moinet
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 415-422;

  5. Garcia, M L

    1. Selective inhibition of relaxation of guinea-pig trachea by charybdotoxin, a potent Ca(++)-activated K+ channel inhibitor.
      T R Jones, L Charette, M L Garcia and G J Kaczorowski
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 697-706;

  6. Garlick, R K

    1. Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain.
      N M Appel, W M Mitchell, R K Garlick, R A Glennon, M Teitler and E B De Souza
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 843-857;

  7. Garvey, J S

    1. On the metallothionein, glutathione and cysteine relationship in rat liver.
      J Hidalgo, J S Garvey and A Armario
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 554-564;

  8. Giacomini, K M

    1. Cimetidine transport in isolated brush border membrane vesicles from bovine choroid plexus.
      M T Whittico, Y A Gang and K M Giacomini
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 615-623;

  9. Gibb, J W

    1. Neurotensin-dopamine interactions in the substantia nigra of the rat brain.
      K M Merchant, L G Bush, J W Gibb and G R Hanson
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 775-780;

  10. Giordano, A L

    1. Antagonist-induced up-regulation of the putative epsilon opioid receptor in rat brain: comparison with kappa, mu and delta opioid receptors.
      A L Giordano, B Nock and T J Cicero
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 536-540;

  11. Giudicelli, J F

    1. Effects of cromakalim and pinacidil on large epicardial and small coronary arteries in conscious dogs.
      J F Giudicelli, C D la Rochelle and A Berdeaux
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 836-842;

  12. Glennon, R A

    1. Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain.
      N M Appel, W M Mitchell, R K Garlick, R A Glennon, M Teitler and E B De Souza
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 843-857;

  13. Gobaille, S

    1. A specific gamma-hydroxybutyrate receptor ligand possesses both antagonistic and anticonvulsant properties.
      M Maitre, V Hechler, P Vayer, S Gobaille, C D Cash, M Schmitt and J J Bourguignon
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 657-663;

  14. Goldfarb, J

    1. Functional interactions in smooth muscle: kinetic characterization of the relaxation and desensitization responses to a beta adrenergic agonist in the rabbit aorta.
      S A Keitz, R Osman, W P Clarke, J Goldfarb and S Maayani
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 650-656;

  15. Goldstein, D S

    1. Fate of tritiated 6-fluorodopamine in rats: a false neurotransmitter for positron emission tomographic imaging of sympathetic innervation and function.
      P C Chang, K Szemeredi, E Grossman, I J Kopin and D S Goldstein
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 809-817;

  16. Gremban, R S

    1. Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils.
      J E Bleasdale, N R Thakur, R S Gremban, G L Bundy, F A Fitzpatrick, R J Smith and S Bunting
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 756-768;

  17. Grossman, E

    1. Fate of tritiated 6-fluorodopamine in rats: a false neurotransmitter for positron emission tomographic imaging of sympathetic innervation and function.
      P C Chang, K Szemeredi, E Grossman, I J Kopin and D S Goldstein
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 809-817;

H

  1. Hahn, E F

    1. Naloxone benzoylhydrazone (NalBzoH) analgesia.
      D Paul, J A Levison, D H Howard, C G Pick, E F Hahn and G W Pasternak
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 769-774;

  2. Han, S P

    1. Calcitonin gene-related peptide is the endogenous mediator of nonadrenergic-noncholinergic vasodilation in rat mesentery.
      S P Han, L Naes and T C Westfall
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 423-428;

  3. Hanson, G R

    1. Neurotensin-dopamine interactions in the substantia nigra of the rat brain.
      K M Merchant, L G Bush, J W Gibb and G R Hanson
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 775-780;

  4. Hara, H

    1. Prevention of hippocampus neuronal damage in ischemic gerbils by a novel lipid peroxidation inhibitor (quinazoline derivative).
      H Hara and K Kogure
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 906-913;

  5. Hart, S D

    1. Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2).
      P C Wong, S D Hart, A M Zaspel, A T Chiu, R J Ardecky, R D Smith and P B Timmermans
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 584-592;

  6. Hashem, A

    1. Pharmacokinetics, anticonvulsant efficacy and adverse effects of the beta-carboline abecarnil, a novel ligand for benzodiazepine receptors, after acute and chronic administration in dogs.
      W Löscher, D Hönack, R Scherkl, A Hashem and H H Frey
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 541-548;

  7. Haubrich, D R

    1. Pharmacology of pravadoline: a new analgesic agent.
      D R Haubrich, S J Ward, E Baizman, M R Bell, J Bradford, R Ferrari, M Miller, M Perrone, A K Pierson and J K Saelens
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 511-522;

  8. Häuser, W

    1. Levodopa delivery from controlled-release polymer matrix: delivery of more than 600 days in vitro and 225 days of elevated plasma levels after subcutaneous implantation in rats.
      B A Sabel, P Dominiak, W Häuser, M J During and A Freese
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 914-922;

  9. Hechler, V

    1. A specific gamma-hydroxybutyrate receptor ligand possesses both antagonistic and anticonvulsant properties.
      M Maitre, V Hechler, P Vayer, S Gobaille, C D Cash, M Schmitt and J J Bourguignon
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 657-663;

  10. Hecquet, B

    1. Stable circadian mechanisms of toxicity of two platinum analogs (cisplatin and carboplatin) despite repeated dosages in mice.
      N A Boughattas, F Lévi, C Fournier, B Hecquet, G Lemaigre, A Roulon, G Mathé and A Reinberg
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 672-679;

  11. Heishman, S J

    1. Acute opioid physical dependence in humans: effect of varying the morphine-naloxone interval II.
      K C Kirby, M L Stitzer and S J Heishman
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 730-737;

  12. Heming, T A

    1. Dipyridamole inhibition of HCO3(-)-Cl- exchange in human erythrocytes.
      T A Heming, C G Vanoye and A Bidani
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 631-635;

  13. Herz, A

    1. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for activation by enkephalin-like opioid peptides after cold water swim stress.
      C G Parsons and A Herz
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 795-802;

  14. Hidalgo, J

    1. On the metallothionein, glutathione and cysteine relationship in rat liver.
      J Hidalgo, J S Garvey and A Armario
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 554-564;

  15. Hönack, D

    1. Pharmacokinetics, anticonvulsant efficacy and adverse effects of the beta-carboline abecarnil, a novel ligand for benzodiazepine receptors, after acute and chronic administration in dogs.
      W Löscher, D Hönack, R Scherkl, A Hashem and H H Frey
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 541-548;

  16. Houlliche, A

    1. SR 33557, a novel calcium entry blocker. I. In vitro isolated tissue studies.
      P Polster, B Christophe, M Van Damme, A Houlliche and P Chatelain
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 593-599;

  17. Howard, D H

    1. Naloxone benzoylhydrazone (NalBzoH) analgesia.
      D Paul, J A Levison, D H Howard, C G Pick, E F Hahn and G W Pasternak
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 769-774;

  18. Hull, K M

    1. L-tyrosine potentiates the anorexia induced by mixed-acting sympathomimetic drugs in hyperphagic rats.
      K M Hull and T J Maher
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 403-409;

I

  1. Ichihara, K

    1. Effects of benzodiazepines on passive avoidance response and latent learning in mice: relationship to benzodiazepine receptors and the cholinergic neuronal system.
      T Nabeshima, K Tohyama, K Ichihara and T Kameyama
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 789-794;
    2. Both d-cis- and l-cis-diltiazem have anti-ischemic action in the isolated, perfused working rat heart.
      Y Nasa, K Ichihara and Y Abiko
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 680-689;

  2. Iizuka, T

    1. Pharmacodynamic characterization of posture-related diuretic and saluretic responses to furosemide in humans.
      T Okaniwa, H Echizen, T Ishizaki, M Kasao and T Iizuka
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 716-723;

  3. Imaizumi, Y

    1. Possible involvement of ATP-sensitive K+ channels in the relaxant response of dog middle cerebral artery to cromakalim.
      K Masuzawa, M Asano, T Matsuda, Y Imaizumi and M Watanabe
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 818-825;

  4. Imbert, T

    1. CRE 10904 [2-(p-fluorophenoxy), 1-(o-hydroxyphenyl)-ethane]: a new diuretic and antihypertensive drug acting by in vivo sulfation.
      R P Garay, J P Labaune, D Mesangeau, C Nazaret, T Imbert and G Moinet
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 415-422;

  5. Ishizaki, T

    1. Pharmacodynamic characterization of posture-related diuretic and saluretic responses to furosemide in humans.
      T Okaniwa, H Echizen, T Ishizaki, M Kasao and T Iizuka
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 716-723;

J

  1. Jacobs, E R

    1. Mechanisms of potassium channel block in rat alveolar epithelial cells.
      E R Jacobs and T E DeCoursey
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 459-472;

  2. James, T L

    1. Opiate-receptor antagonist improves metabolic recovery and limits neurochemical alterations associated with reperfusion after global brain ischemia in rats.
      A I Faden, R Shirane, L H Chang, T L James, M Lemke and P R Weinstein
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 451-458;

  3. Jeck, C D

    1. Use-dependent effects of lidocaine in neonatal and adult ventricular myocardium.
      C D Jeck and M R Rosen
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 738-743;

  4. Johnson, D H

    1. Effect of aging on hepatic biotransformation in female Fischer 344 rats: changes in sulfotransferase activities are consistent with known gender-related changes in pituitary growth hormone secretion in aging animals.
      R E Galinsky, D H Johnson, R E Kane and M R Franklin
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 577-583;

  5. Jones, T R

    1. Selective inhibition of relaxation of guinea-pig trachea by charybdotoxin, a potent Ca(++)-activated K+ channel inhibitor.
      T R Jones, L Charette, M L Garcia and G J Kaczorowski
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 697-706;

  6. Joo, F

    1. Resiniferatoxin: an ultrapotent selective modulator of capsaicin-sensitive primary afferent neurons.
      J Szolcsanyi, A Szallasi, Z Szallasi, F Joo and P M Blumberg
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 923-928;

K

  1. Kaczorowski, G J

    1. Selective inhibition of relaxation of guinea-pig trachea by charybdotoxin, a potent Ca(++)-activated K+ channel inhibitor.
      T R Jones, L Charette, M L Garcia and G J Kaczorowski
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 697-706;

  2. Kállay, Z

    1. Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. I. Polyaspartic acid binds gentamicin and displaces it from negatively charged phospholipid layers in vitro.
      B K Kishore, Z Kállay, P Lambricht, G Laurent and P M Tulkens
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 867-874;

  3. Kameyama, T

    1. Effects of benzodiazepines on passive avoidance response and latent learning in mice: relationship to benzodiazepine receptors and the cholinergic neuronal system.
      T Nabeshima, K Tohyama, K Ichihara and T Kameyama
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 789-794;

  4. Kane, R E

    1. Effect of aging on hepatic biotransformation in female Fischer 344 rats: changes in sulfotransferase activities are consistent with known gender-related changes in pituitary growth hormone secretion in aging animals.
      R E Galinsky, D H Johnson, R E Kane and M R Franklin
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 577-583;

  5. Kasao, M

    1. Pharmacodynamic characterization of posture-related diuretic and saluretic responses to furosemide in humans.
      T Okaniwa, H Echizen, T Ishizaki, M Kasao and T Iizuka
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 716-723;

  6. Kawabata, T

    1. Protective effect of a novel calcium blocker, S-312-d, on ischemic acute renal failure in rat.
      T Shimizu, T Kawabata and M Nakamura
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 484-490;

  7. Kawai, R

    1. Kinetic analysis of the opiate antagonist cyclofoxy in rat brain: simultaneous infusion of active and inactive enantiomers.
      R Kawai, Y Sawada, M Channing, B Dunn, A H Newman, K C Rice and R G Blasberg
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 826-835;

  8. Keitz, S A

    1. Functional interactions in smooth muscle: kinetic characterization of the relaxation and desensitization responses to a beta adrenergic agonist in the rabbit aorta.
      S A Keitz, R Osman, W P Clarke, J Goldfarb and S Maayani
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 650-656;

  9. Kirby, K C

    1. Acute opioid physical dependence in humans: effect of varying the morphine-naloxone interval II.
      K C Kirby, M L Stitzer and S J Heishman
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 730-737;

  10. Kishore, B K

    1. Protection against gentamicin-induced early renal alterations (phospholipidosis and increased DNA synthesis) by coadministration of poly-L-aspartic acid.
      D Beauchamp, G Laurent, P Maldague, S Abid, B K Kishore and P M Tulkens
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 858-866;
    2. Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. I. Polyaspartic acid binds gentamicin and displaces it from negatively charged phospholipid layers in vitro.
      B K Kishore, Z Kállay, P Lambricht, G Laurent and P M Tulkens
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 867-874;
    3. Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. II. Comparative in vitro and in vivo studies with poly-L-aspartic, poly-L-glutamic and poly-D-glutamic acids.
      B K Kishore, P Lambricht, G Laurent, P Maldague, R Wagner and P M Tulkens
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 875-885;

  11. Kogure, K

    1. Prevention of hippocampus neuronal damage in ischemic gerbils by a novel lipid peroxidation inhibitor (quinazoline derivative).
      H Hara and K Kogure
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 906-913;

  12. Kopin, I J

    1. Fate of tritiated 6-fluorodopamine in rats: a false neurotransmitter for positron emission tomographic imaging of sympathetic innervation and function.
      P C Chang, K Szemeredi, E Grossman, I J Kopin and D S Goldstein
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 809-817;

  13. Kumagai, Y

    1. A new metabolic pathway of morphine: in vivo and in vitro formation of morphinone and morphine-glutathione adduct in guinea pig.
      Y Kumagai, T Todaka and S Toki
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 504-510;

  14. Kwok, Y N

    1. Augmentation of release of gastric somatostatin-like immunoreactivity by adenosine, adenosine triphosphate and their analogs.
      Y N Kwok, C McIntosh and J Brown
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 781-788;

L

  1. Labaune, J P

    1. CRE 10904 [2-(p-fluorophenoxy), 1-(o-hydroxyphenyl)-ethane]: a new diuretic and antihypertensive drug acting by in vivo sulfation.
      R P Garay, J P Labaune, D Mesangeau, C Nazaret, T Imbert and G Moinet
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 415-422;

  2. Labbe, G

    1. Stereoselective and nonstereoselective effects of ibuprofen enantiomers on mitochondrial beta-oxidation of fatty acids.
      E Freneaux, B Fromenty, A Berson, G Labbe, C Degott, P Letteron, D Larrey and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 529-535;

  3. Lambricht, P

    1. Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. I. Polyaspartic acid binds gentamicin and displaces it from negatively charged phospholipid layers in vitro.
      B K Kishore, Z Kállay, P Lambricht, G Laurent and P M Tulkens
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 867-874;
    2. Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. II. Comparative in vitro and in vivo studies with poly-L-aspartic, poly-L-glutamic and poly-D-glutamic acids.
      B K Kishore, P Lambricht, G Laurent, P Maldague, R Wagner and P M Tulkens
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 875-885;

  4. la Rochelle, C D

    1. Effects of cromakalim and pinacidil on large epicardial and small coronary arteries in conscious dogs.
      J F Giudicelli, C D la Rochelle and A Berdeaux
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 836-842;

  5. Larrey, D

    1. Stereoselective and nonstereoselective effects of ibuprofen enantiomers on mitochondrial beta-oxidation of fatty acids.
      E Freneaux, B Fromenty, A Berson, G Labbe, C Degott, P Letteron, D Larrey and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 529-535;

  6. Laruel, R

    1. SR 33557, a novel calcium entry blocker. II. Interactions with 1,4-dihydropyridine, phenylalkylamine and benzothiazepine binding sites in rat heart sarcolemmal membranes.
      P Nokin, M Clinet, P Beaufort, L Meysmans, R Laruel and P Chatelain
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 600-607;

  7. Laurent, G

    1. Protection against gentamicin-induced early renal alterations (phospholipidosis and increased DNA synthesis) by coadministration of poly-L-aspartic acid.
      D Beauchamp, G Laurent, P Maldague, S Abid, B K Kishore and P M Tulkens
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 858-866;
    2. Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. I. Polyaspartic acid binds gentamicin and displaces it from negatively charged phospholipid layers in vitro.
      B K Kishore, Z Kállay, P Lambricht, G Laurent and P M Tulkens
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 867-874;
    3. Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. II. Comparative in vitro and in vivo studies with poly-L-aspartic, poly-L-glutamic and poly-D-glutamic acids.
      B K Kishore, P Lambricht, G Laurent, P Maldague, R Wagner and P M Tulkens
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 875-885;

  8. Lederer, W J

    1. Modulation of ATP-sensitive K+ channel activity and contractile behavior in mammalian ventricle by the potassium channel openers cromakalim and RP49356.
      C Ripoll, W J Lederer and C G Nichols
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 429-435;

  9. Lemaigre, G

    1. Stable circadian mechanisms of toxicity of two platinum analogs (cisplatin and carboplatin) despite repeated dosages in mice.
      N A Boughattas, F Lévi, C Fournier, B Hecquet, G Lemaigre, A Roulon, G Mathé and A Reinberg
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 672-679;

  10. Lemke, M

    1. Opiate-receptor antagonist improves metabolic recovery and limits neurochemical alterations associated with reperfusion after global brain ischemia in rats.
      A I Faden, R Shirane, L H Chang, T L James, M Lemke and P R Weinstein
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 451-458;
    2. Effects of TRH-analog treatment on tissue cations, phospholipids and energy metabolism after spinal cord injury.
      A I Faden, S W Yum, M Lemke and R Vink
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 608-614;

  11. Letteron, P

    1. Stereoselective and nonstereoselective effects of ibuprofen enantiomers on mitochondrial beta-oxidation of fatty acids.
      E Freneaux, B Fromenty, A Berson, G Labbe, C Degott, P Letteron, D Larrey and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 529-535;

  12. Lévi, F

    1. Stable circadian mechanisms of toxicity of two platinum analogs (cisplatin and carboplatin) despite repeated dosages in mice.
      N A Boughattas, F Lévi, C Fournier, B Hecquet, G Lemaigre, A Roulon, G Mathé and A Reinberg
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 672-679;

  13. Levin, S

    1. Effect of the leukotriene B4 receptor antagonist SC-41930 on colonic inflammation in rat, guinea pig and rabbit.
      D J Fretland, D Widomski, B S Tsai, J M Zemaitis, S Levin, S W Djuric, R L Shone and T S Gaginella
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 572-576;

  14. Levison, J A

    1. Naloxone benzoylhydrazone (NalBzoH) analgesia.
      D Paul, J A Levison, D H Howard, C G Pick, E F Hahn and G W Pasternak
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 769-774;

  15. Lloyd, G K

    1. The activity of zolpidem and other hypnotics within the gamma-aminobutyric acid (GABAA) receptor supramolecular complex, as determined by 35S-t-butylbicyclophosphorothionate (35S-TBPS) binding to rat cerebral cortex membranes.
      G K Lloyd, G Danielou and F Thuret
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 690-696;

  16. Löscher, W

    1. Pharmacokinetics, anticonvulsant efficacy and adverse effects of the beta-carboline abecarnil, a novel ligand for benzodiazepine receptors, after acute and chronic administration in dogs.
      W Löscher, D Hönack, R Scherkl, A Hashem and H H Frey
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 541-548;

M

  1. Maayani, S

    1. Functional interactions in smooth muscle: kinetic characterization of the relaxation and desensitization responses to a beta adrenergic agonist in the rabbit aorta.
      S A Keitz, R Osman, W P Clarke, J Goldfarb and S Maayani
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 650-656;

  2. Maher, T J

    1. L-tyrosine potentiates the anorexia induced by mixed-acting sympathomimetic drugs in hyperphagic rats.
      K M Hull and T J Maher
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 403-409;

  3. Maitre, M

    1. A specific gamma-hydroxybutyrate receptor ligand possesses both antagonistic and anticonvulsant properties.
      M Maitre, V Hechler, P Vayer, S Gobaille, C D Cash, M Schmitt and J J Bourguignon
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 657-663;

  4. Maldague, P

    1. Protection against gentamicin-induced early renal alterations (phospholipidosis and increased DNA synthesis) by coadministration of poly-L-aspartic acid.
      D Beauchamp, G Laurent, P Maldague, S Abid, B K Kishore and P M Tulkens
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 858-866;
    2. Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. II. Comparative in vitro and in vivo studies with poly-L-aspartic, poly-L-glutamic and poly-D-glutamic acids.
      B K Kishore, P Lambricht, G Laurent, P Maldague, R Wagner and P M Tulkens
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 875-885;

  5. Martin, B R

    1. Characterization of the lipophilicity of natural and synthetic analogs of delta 9-tetrahydrocannabinol and its relationship to pharmacological potency.
      B F Thomas, D R Compton and B R Martin
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 624-630;

  6. Martin, W R

    1. Precipitated abstinence in orally dosed benzodiazepine-dependent dogs.
      W R Martin, J W Sloan and E Wala
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 744-755;

  7. Masuzawa, K

    1. Possible involvement of ATP-sensitive K+ channels in the relaxant response of dog middle cerebral artery to cromakalim.
      K Masuzawa, M Asano, T Matsuda, Y Imaizumi and M Watanabe
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 818-825;

  8. Mathé, G

    1. Stable circadian mechanisms of toxicity of two platinum analogs (cisplatin and carboplatin) despite repeated dosages in mice.
      N A Boughattas, F Lévi, C Fournier, B Hecquet, G Lemaigre, A Roulon, G Mathé and A Reinberg
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 672-679;

  9. Matsuda, T

    1. Possible involvement of ATP-sensitive K+ channels in the relaxant response of dog middle cerebral artery to cromakalim.
      K Masuzawa, M Asano, T Matsuda, Y Imaizumi and M Watanabe
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 818-825;

  10. McIntosh, C

    1. Augmentation of release of gastric somatostatin-like immunoreactivity by adenosine, adenosine triphosphate and their analogs.
      Y N Kwok, C McIntosh and J Brown
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 781-788;

  11. Merchant, K M

    1. Neurotensin-dopamine interactions in the substantia nigra of the rat brain.
      K M Merchant, L G Bush, J W Gibb and G R Hanson
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 775-780;

  12. Mesangeau, D

    1. CRE 10904 [2-(p-fluorophenoxy), 1-(o-hydroxyphenyl)-ethane]: a new diuretic and antihypertensive drug acting by in vivo sulfation.
      R P Garay, J P Labaune, D Mesangeau, C Nazaret, T Imbert and G Moinet
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 415-422;

  13. Meyer, E R

    1. Influence of chronic alcohol administration on representative indices of puberty and sexual maturation in male rats and the development of their progeny.
      T J Cicero, M L Adams, L O'Connor, B Nock, E R Meyer and D Wozniak
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 707-715;

  14. Meysmans, L

    1. SR 33557, a novel calcium entry blocker. II. Interactions with 1,4-dihydropyridine, phenylalkylamine and benzothiazepine binding sites in rat heart sarcolemmal membranes.
      P Nokin, M Clinet, P Beaufort, L Meysmans, R Laruel and P Chatelain
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 600-607;

  15. Miller, M

    1. Pharmacology of pravadoline: a new analgesic agent.
      D R Haubrich, S J Ward, E Baizman, M R Bell, J Bradford, R Ferrari, M Miller, M Perrone, A K Pierson and J K Saelens
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 511-522;

  16. Mitchell, W M

    1. Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain.
      N M Appel, W M Mitchell, R K Garlick, R A Glennon, M Teitler and E B De Souza
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 843-857;

  17. Moinet, G

    1. CRE 10904 [2-(p-fluorophenoxy), 1-(o-hydroxyphenyl)-ethane]: a new diuretic and antihypertensive drug acting by in vivo sulfation.
      R P Garay, J P Labaune, D Mesangeau, C Nazaret, T Imbert and G Moinet
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 415-422;

  18. Moons, W M

    1. Renal disposition and effects of naproxen and its l-enantiomer in the isolated perfused rat kidney.
      P G Cox, W M Moons, F G Russel and C A van Ginneken
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 491-496;

  19. Mosberg, H I

    1. Opioid agonist and antagonist antinociceptive properties of [D-Ala2,Leu5,Cys6]enkephalin: selective actions at the deltanoncomplexed site.
      J A Qi, W D Bowen, H I Mosberg, R B Rothman and F Porreca
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 636-641;

N

  1. Nabeshima, T

    1. Effects of benzodiazepines on passive avoidance response and latent learning in mice: relationship to benzodiazepine receptors and the cholinergic neuronal system.
      T Nabeshima, K Tohyama, K Ichihara and T Kameyama
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 789-794;

  2. Naes, L

    1. Calcitonin gene-related peptide is the endogenous mediator of nonadrenergic-noncholinergic vasodilation in rat mesentery.
      S P Han, L Naes and T C Westfall
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 423-428;

  3. Nakamura, M

    1. Protective effect of a novel calcium blocker, S-312-d, on ischemic acute renal failure in rat.
      T Shimizu, T Kawabata and M Nakamura
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 484-490;

  4. Nasa, Y

    1. Both d-cis- and l-cis-diltiazem have anti-ischemic action in the isolated, perfused working rat heart.
      Y Nasa, K Ichihara and Y Abiko
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 680-689;

  5. Nazaret, C

    1. CRE 10904 [2-(p-fluorophenoxy), 1-(o-hydroxyphenyl)-ethane]: a new diuretic and antihypertensive drug acting by in vivo sulfation.
      R P Garay, J P Labaune, D Mesangeau, C Nazaret, T Imbert and G Moinet
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 415-422;

  6. Newman, A H

    1. Kinetic analysis of the opiate antagonist cyclofoxy in rat brain: simultaneous infusion of active and inactive enantiomers.
      R Kawai, Y Sawada, M Channing, B Dunn, A H Newman, K C Rice and R G Blasberg
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 826-835;

  7. Nichols, C G

    1. Modulation of ATP-sensitive K+ channel activity and contractile behavior in mammalian ventricle by the potassium channel openers cromakalim and RP49356.
      C Ripoll, W J Lederer and C G Nichols
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 429-435;

  8. Nock, B

    1. Antagonist-induced up-regulation of the putative epsilon opioid receptor in rat brain: comparison with kappa, mu and delta opioid receptors.
      A L Giordano, B Nock and T J Cicero
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 536-540;
    2. Influence of chronic alcohol administration on representative indices of puberty and sexual maturation in male rats and the development of their progeny.
      T J Cicero, M L Adams, L O'Connor, B Nock, E R Meyer and D Wozniak
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 707-715;

  9. Nokin, P

    1. SR 33557, a novel calcium entry blocker. II. Interactions with 1,4-dihydropyridine, phenylalkylamine and benzothiazepine binding sites in rat heart sarcolemmal membranes.
      P Nokin, M Clinet, P Beaufort, L Meysmans, R Laruel and P Chatelain
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 600-607;

O

  1. O'Connor, L

    1. Influence of chronic alcohol administration on representative indices of puberty and sexual maturation in male rats and the development of their progeny.
      T J Cicero, M L Adams, L O'Connor, B Nock, E R Meyer and D Wozniak
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 707-715;

  2. Okaniwa, T

    1. Pharmacodynamic characterization of posture-related diuretic and saluretic responses to furosemide in humans.
      T Okaniwa, H Echizen, T Ishizaki, M Kasao and T Iizuka
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 716-723;

  3. Osman, R

    1. Functional interactions in smooth muscle: kinetic characterization of the relaxation and desensitization responses to a beta adrenergic agonist in the rabbit aorta.
      S A Keitz, R Osman, W P Clarke, J Goldfarb and S Maayani
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 650-656;

P

  1. Pardridge, W M

    1. Evaluation of cationized rat albumin as a potential blood-brain barrier drug transport vector.
      W M Pardridge, D Triguero, J Buciak and J Yang
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 893-899;

  2. Parsons, C G

    1. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for activation by enkephalin-like opioid peptides after cold water swim stress.
      C G Parsons and A Herz
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 795-802;

  3. Pasternak, G W

    1. Naloxone benzoylhydrazone (NalBzoH) analgesia.
      D Paul, J A Levison, D H Howard, C G Pick, E F Hahn and G W Pasternak
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 769-774;

  4. Paul, D

    1. Naloxone benzoylhydrazone (NalBzoH) analgesia.
      D Paul, J A Levison, D H Howard, C G Pick, E F Hahn and G W Pasternak
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 769-774;

  5. Pavlou, H N

    1. Genetically determined steady-state interaction between encainide and quinidine in patients with arrhythmias.
      J Turgeon, H N Pavlou, W Wong, C Funck-Brentano and D M Roden
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 642-649;

  6. Perrone, M

    1. Pharmacology of pravadoline: a new analgesic agent.
      D R Haubrich, S J Ward, E Baizman, M R Bell, J Bradford, R Ferrari, M Miller, M Perrone, A K Pierson and J K Saelens
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 511-522;

  7. Pessayre, D

    1. Stereoselective and nonstereoselective effects of ibuprofen enantiomers on mitochondrial beta-oxidation of fatty acids.
      E Freneaux, B Fromenty, A Berson, G Labbe, C Degott, P Letteron, D Larrey and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 529-535;

  8. Peters, S C

    1. A comparison of the effects of cholinergic and dopaminergic agents on scopolamine-induced hyperactivity in mice.
      H E Shannon and S C Peters
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 549-553;

  9. Pick, C G

    1. Naloxone benzoylhydrazone (NalBzoH) analgesia.
      D Paul, J A Levison, D H Howard, C G Pick, E F Hahn and G W Pasternak
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 769-774;

  10. Pierson, A K

    1. Pharmacology of pravadoline: a new analgesic agent.
      D R Haubrich, S J Ward, E Baizman, M R Bell, J Bradford, R Ferrari, M Miller, M Perrone, A K Pierson and J K Saelens
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 511-522;

  11. Pillar, J S

    1. Evidence that peptidoleukotriene is a prerequisite for antigen-dependent thromboxane synthesis in IgG1-passively sensitized guinea pig lungs.
      J B Cheng, J S Pillar, M J Conklyn, R Breslow, J T Shirley and H J Showell
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 664-671;

  12. Polster, P

    1. SR 33557, a novel calcium entry blocker. I. In vitro isolated tissue studies.
      P Polster, B Christophe, M Van Damme, A Houlliche and P Chatelain
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 593-599;

  13. Porreca, F

    1. Opioid agonist and antagonist antinociceptive properties of [D-Ala2,Leu5,Cys6]enkephalin: selective actions at the deltanoncomplexed site.
      J A Qi, W D Bowen, H I Mosberg, R B Rothman and F Porreca
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 636-641;

Q

  1. Qi, J A

    1. Opioid agonist and antagonist antinociceptive properties of [D-Ala2,Leu5,Cys6]enkephalin: selective actions at the deltanoncomplexed site.
      J A Qi, W D Bowen, H I Mosberg, R B Rothman and F Porreca
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 636-641;

R

  1. Ramwell, P W

    1. Endothelium-mediated effects of N-substituted arginines on the isolated perfused rat kidney.
      M Y Farhat, P W Ramwell and G Thomas
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 473-477;

  2. Reinberg, A

    1. Stable circadian mechanisms of toxicity of two platinum analogs (cisplatin and carboplatin) despite repeated dosages in mice.
      N A Boughattas, F Lévi, C Fournier, B Hecquet, G Lemaigre, A Roulon, G Mathé and A Reinberg
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 672-679;

  3. Rice, K C

    1. Kinetic analysis of the opiate antagonist cyclofoxy in rat brain: simultaneous infusion of active and inactive enantiomers.
      R Kawai, Y Sawada, M Channing, B Dunn, A H Newman, K C Rice and R G Blasberg
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 826-835;

  4. Ripoll, C

    1. Modulation of ATP-sensitive K+ channel activity and contractile behavior in mammalian ventricle by the potassium channel openers cromakalim and RP49356.
      C Ripoll, W J Lederer and C G Nichols
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 429-435;

  5. Roden, D M

    1. Genetically determined steady-state interaction between encainide and quinidine in patients with arrhythmias.
      J Turgeon, H N Pavlou, W Wong, C Funck-Brentano and D M Roden
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 642-649;

  6. Rosen, M R

    1. Use-dependent effects of lidocaine in neonatal and adult ventricular myocardium.
      C D Jeck and M R Rosen
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 738-743;

  7. Rothman, R B

    1. Opioid agonist and antagonist antinociceptive properties of [D-Ala2,Leu5,Cys6]enkephalin: selective actions at the deltanoncomplexed site.
      J A Qi, W D Bowen, H I Mosberg, R B Rothman and F Porreca
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 636-641;

  8. Roudebush, R E

    1. Suppressive effects of morphine pellet implants on in vivo parameters of immune function.
      H U Bryant and R E Roudebush
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 410-414;

  9. Roulon, A

    1. Stable circadian mechanisms of toxicity of two platinum analogs (cisplatin and carboplatin) despite repeated dosages in mice.
      N A Boughattas, F Lévi, C Fournier, B Hecquet, G Lemaigre, A Roulon, G Mathé and A Reinberg
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 672-679;

  10. Russel, F G

    1. Renal disposition and effects of naproxen and its l-enantiomer in the isolated perfused rat kidney.
      P G Cox, W M Moons, F G Russel and C A van Ginneken
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 491-496;

S

  1. Sabel, B A

    1. Levodopa delivery from controlled-release polymer matrix: delivery of more than 600 days in vitro and 225 days of elevated plasma levels after subcutaneous implantation in rats.
      B A Sabel, P Dominiak, W Häuser, M J During and A Freese
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 914-922;

  2. Saelens, J K

    1. Pharmacology of pravadoline: a new analgesic agent.
      D R Haubrich, S J Ward, E Baizman, M R Bell, J Bradford, R Ferrari, M Miller, M Perrone, A K Pierson and J K Saelens
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 511-522;

  3. Sánchez, A

    1. Naloxone potentiation of cardiovascular responses to sympathomimetic amines in the rat.
      M Feria, C Alvarez, J Domínguez, A Sánchez and J Boada
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 523-528;

  4. Sawada, Y

    1. Kinetic analysis of the opiate antagonist cyclofoxy in rat brain: simultaneous infusion of active and inactive enantiomers.
      R Kawai, Y Sawada, M Channing, B Dunn, A H Newman, K C Rice and R G Blasberg
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 826-835;

  5. Scherkl, R

    1. Pharmacokinetics, anticonvulsant efficacy and adverse effects of the beta-carboline abecarnil, a novel ligand for benzodiazepine receptors, after acute and chronic administration in dogs.
      W Löscher, D Hönack, R Scherkl, A Hashem and H H Frey
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 541-548;

  6. Schiemann, W P

    1. On the ability of endogenous adenosine to regulate purine nucleoside receptor binding of antagonists in smooth muscle membranes.
      W P Schiemann, J M Walther and I L Buxton
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 886-892;

  7. Schmidt, C J

    1. Selective 5-hydroxytryptamine2 receptor antagonists protect against the neurotoxicity of methylenedioxymethamphetamine in rats.
      C J Schmidt, G M Abbate, C K Black and V L Taylor
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 478-483;

  8. Schmitt, M

    1. A specific gamma-hydroxybutyrate receptor ligand possesses both antagonistic and anticonvulsant properties.
      M Maitre, V Hechler, P Vayer, S Gobaille, C D Cash, M Schmitt and J J Bourguignon
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 657-663;

  9. Shannon, H E

    1. A comparison of the effects of cholinergic and dopaminergic agents on scopolamine-induced hyperactivity in mice.
      H E Shannon and S C Peters
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 549-553;

  10. Shimizu, T

    1. Protective effect of a novel calcium blocker, S-312-d, on ischemic acute renal failure in rat.
      T Shimizu, T Kawabata and M Nakamura
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 484-490;

  11. Shirane, R

    1. Opiate-receptor antagonist improves metabolic recovery and limits neurochemical alterations associated with reperfusion after global brain ischemia in rats.
      A I Faden, R Shirane, L H Chang, T L James, M Lemke and P R Weinstein
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 451-458;

  12. Shirley, J T

    1. Evidence that peptidoleukotriene is a prerequisite for antigen-dependent thromboxane synthesis in IgG1-passively sensitized guinea pig lungs.
      J B Cheng, J S Pillar, M J Conklyn, R Breslow, J T Shirley and H J Showell
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 664-671;

  13. Shone, R L

    1. Effect of the leukotriene B4 receptor antagonist SC-41930 on colonic inflammation in rat, guinea pig and rabbit.
      D J Fretland, D Widomski, B S Tsai, J M Zemaitis, S Levin, S W Djuric, R L Shone and T S Gaginella
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 572-576;

  14. Showell, H J

    1. Evidence that peptidoleukotriene is a prerequisite for antigen-dependent thromboxane synthesis in IgG1-passively sensitized guinea pig lungs.
      J B Cheng, J S Pillar, M J Conklyn, R Breslow, J T Shirley and H J Showell
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 664-671;

  15. Sloan, J W

    1. Precipitated abstinence in orally dosed benzodiazepine-dependent dogs.
      W R Martin, J W Sloan and E Wala
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 744-755;

  16. Smith, R D

    1. Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2).
      P C Wong, S D Hart, A M Zaspel, A T Chiu, R J Ardecky, R D Smith and P B Timmermans
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 584-592;

  17. Smith, R J

    1. Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils.
      J E Bleasdale, N R Thakur, R S Gremban, G L Bundy, F A Fitzpatrick, R J Smith and S Bunting
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 756-768;

  18. Sokol, P P

    1. Effect of DQ-2556, a new cephalosporin, on organic ion transport in renal plasma membrane vesicles from the dog, rabbit and rat.
      P P Sokol
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 436-441;

  19. Stitzer, M L

    1. Acute opioid physical dependence in humans: effect of varying the morphine-naloxone interval II.
      K C Kirby, M L Stitzer and S J Heishman
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 730-737;

  20. Szallasi, A

    1. Resiniferatoxin: an ultrapotent selective modulator of capsaicin-sensitive primary afferent neurons.
      J Szolcsanyi, A Szallasi, Z Szallasi, F Joo and P M Blumberg
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 923-928;

  21. Szallasi, Z

    1. Resiniferatoxin: an ultrapotent selective modulator of capsaicin-sensitive primary afferent neurons.
      J Szolcsanyi, A Szallasi, Z Szallasi, F Joo and P M Blumberg
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 923-928;

  22. Szemeredi, K

    1. Fate of tritiated 6-fluorodopamine in rats: a false neurotransmitter for positron emission tomographic imaging of sympathetic innervation and function.
      P C Chang, K Szemeredi, E Grossman, I J Kopin and D S Goldstein
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 809-817;

  23. Szolcsanyi, J

    1. Resiniferatoxin: an ultrapotent selective modulator of capsaicin-sensitive primary afferent neurons.
      J Szolcsanyi, A Szallasi, Z Szallasi, F Joo and P M Blumberg
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 923-928;

T

  1. Tanaka, H

    1. Pharmacokinetics of recombinant human granulocyte colony-stimulating factor studied in the rat by a sandwich enzyme-linked immunosorbent assay.
      H Tanaka and T Tokiwa
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 724-729;

  2. Taupin, V

    1. In vivo treatment with benzodiazepines inhibits murine phagocyte oxidative metabolism and production of interleukin 1, tumor necrosis factor and interleukin-6.
      F Zavala, V Taupin and B Descamps-Latscha
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 442-450;

  3. Taylor, V L

    1. Selective 5-hydroxytryptamine2 receptor antagonists protect against the neurotoxicity of methylenedioxymethamphetamine in rats.
      C J Schmidt, G M Abbate, C K Black and V L Taylor
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 478-483;

  4. Teitler, M

    1. Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain.
      N M Appel, W M Mitchell, R K Garlick, R A Glennon, M Teitler and E B De Souza
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 843-857;

  5. ten Bruggencate, G

    1. Nonopioid actions of the kappa-opioid receptor agonists, U 50488H and U 69593 on electrophysiologic properties of hippocampal CA3 neurons in vitro.
      C Alzheimer and G ten Bruggencate
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 900-905;

  6. Thakur, N R

    1. Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils.
      J E Bleasdale, N R Thakur, R S Gremban, G L Bundy, F A Fitzpatrick, R J Smith and S Bunting
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 756-768;

  7. Thomas, B F

    1. Characterization of the lipophilicity of natural and synthetic analogs of delta 9-tetrahydrocannabinol and its relationship to pharmacological potency.
      B F Thomas, D R Compton and B R Martin
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 624-630;

  8. Thomas, G

    1. Endothelium-mediated effects of N-substituted arginines on the isolated perfused rat kidney.
      M Y Farhat, P W Ramwell and G Thomas
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 473-477;

  9. Thuret, F

    1. The activity of zolpidem and other hypnotics within the gamma-aminobutyric acid (GABAA) receptor supramolecular complex, as determined by 35S-t-butylbicyclophosphorothionate (35S-TBPS) binding to rat cerebral cortex membranes.
      G K Lloyd, G Danielou and F Thuret
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 690-696;

  10. Timmermans, P B

    1. Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2).
      P C Wong, S D Hart, A M Zaspel, A T Chiu, R J Ardecky, R D Smith and P B Timmermans
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 584-592;

  11. Todaka, T

    1. A new metabolic pathway of morphine: in vivo and in vitro formation of morphinone and morphine-glutathione adduct in guinea pig.
      Y Kumagai, T Todaka and S Toki
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 504-510;

  12. Tohyama, K

    1. Effects of benzodiazepines on passive avoidance response and latent learning in mice: relationship to benzodiazepine receptors and the cholinergic neuronal system.
      T Nabeshima, K Tohyama, K Ichihara and T Kameyama
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 789-794;

  13. Toki, S

    1. A new metabolic pathway of morphine: in vivo and in vitro formation of morphinone and morphine-glutathione adduct in guinea pig.
      Y Kumagai, T Todaka and S Toki
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 504-510;

  14. Tokiwa, T

    1. Pharmacokinetics of recombinant human granulocyte colony-stimulating factor studied in the rat by a sandwich enzyme-linked immunosorbent assay.
      H Tanaka and T Tokiwa
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 724-729;

  15. Trachte, G J

    1. Neuromodulatory effects of atrial natriuretic factor are independent of guanylate cyclase in adrenergic neuronal pheochromocytoma cells.
      J G Drewett, R J Ziegler and G J Trachte
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 497-503;

  16. Triguero, D

    1. Evaluation of cationized rat albumin as a potential blood-brain barrier drug transport vector.
      W M Pardridge, D Triguero, J Buciak and J Yang
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 893-899;

  17. Tsai, B S

    1. Effect of the leukotriene B4 receptor antagonist SC-41930 on colonic inflammation in rat, guinea pig and rabbit.
      D J Fretland, D Widomski, B S Tsai, J M Zemaitis, S Levin, S W Djuric, R L Shone and T S Gaginella
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 572-576;

  18. Tulkens, P M

    1. Protection against gentamicin-induced early renal alterations (phospholipidosis and increased DNA synthesis) by coadministration of poly-L-aspartic acid.
      D Beauchamp, G Laurent, P Maldague, S Abid, B K Kishore and P M Tulkens
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 858-866;
    2. Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. I. Polyaspartic acid binds gentamicin and displaces it from negatively charged phospholipid layers in vitro.
      B K Kishore, Z Kállay, P Lambricht, G Laurent and P M Tulkens
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 867-874;
    3. Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. II. Comparative in vitro and in vivo studies with poly-L-aspartic, poly-L-glutamic and poly-D-glutamic acids.
      B K Kishore, P Lambricht, G Laurent, P Maldague, R Wagner and P M Tulkens
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 875-885;

  19. Turgeon, J

    1. Genetically determined steady-state interaction between encainide and quinidine in patients with arrhythmias.
      J Turgeon, H N Pavlou, W Wong, C Funck-Brentano and D M Roden
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 642-649;

V

  1. Van Damme, M

    1. SR 33557, a novel calcium entry blocker. I. In vitro isolated tissue studies.
      P Polster, B Christophe, M Van Damme, A Houlliche and P Chatelain
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 593-599;

  2. van Ginneken, C A

    1. Renal disposition and effects of naproxen and its l-enantiomer in the isolated perfused rat kidney.
      P G Cox, W M Moons, F G Russel and C A van Ginneken
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 491-496;

  3. Vanoye, C G

    1. Dipyridamole inhibition of HCO3(-)-Cl- exchange in human erythrocytes.
      T A Heming, C G Vanoye and A Bidani
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 631-635;

  4. Vayer, P

    1. A specific gamma-hydroxybutyrate receptor ligand possesses both antagonistic and anticonvulsant properties.
      M Maitre, V Hechler, P Vayer, S Gobaille, C D Cash, M Schmitt and J J Bourguignon
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 657-663;

  5. Vink, R

    1. Effects of TRH-analog treatment on tissue cations, phospholipids and energy metabolism after spinal cord injury.
      A I Faden, S W Yum, M Lemke and R Vink
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 608-614;

W

  1. Wagner, R

    1. Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. II. Comparative in vitro and in vivo studies with poly-L-aspartic, poly-L-glutamic and poly-D-glutamic acids.
      B K Kishore, P Lambricht, G Laurent, P Maldague, R Wagner and P M Tulkens
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 875-885;

  2. Wala, E

    1. Precipitated abstinence in orally dosed benzodiazepine-dependent dogs.
      W R Martin, J W Sloan and E Wala
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 744-755;

  3. Walther, J M

    1. On the ability of endogenous adenosine to regulate purine nucleoside receptor binding of antagonists in smooth muscle membranes.
      W P Schiemann, J M Walther and I L Buxton
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 886-892;

  4. Ward, S J

    1. Pharmacology of pravadoline: a new analgesic agent.
      D R Haubrich, S J Ward, E Baizman, M R Bell, J Bradford, R Ferrari, M Miller, M Perrone, A K Pierson and J K Saelens
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 511-522;

  5. Watanabe, M

    1. Possible involvement of ATP-sensitive K+ channels in the relaxant response of dog middle cerebral artery to cromakalim.
      K Masuzawa, M Asano, T Matsuda, Y Imaizumi and M Watanabe
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 818-825;

  6. Weinstein, P R

    1. Opiate-receptor antagonist improves metabolic recovery and limits neurochemical alterations associated with reperfusion after global brain ischemia in rats.
      A I Faden, R Shirane, L H Chang, T L James, M Lemke and P R Weinstein
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 451-458;

  7. Westfall, T C

    1. Calcitonin gene-related peptide is the endogenous mediator of nonadrenergic-noncholinergic vasodilation in rat mesentery.
      S P Han, L Naes and T C Westfall
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 423-428;

  8. Whittico, M T

    1. Cimetidine transport in isolated brush border membrane vesicles from bovine choroid plexus.
      M T Whittico, Y A Gang and K M Giacomini
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 615-623;

  9. Widomski, D

    1. Effect of the leukotriene B4 receptor antagonist SC-41930 on colonic inflammation in rat, guinea pig and rabbit.
      D J Fretland, D Widomski, B S Tsai, J M Zemaitis, S Levin, S W Djuric, R L Shone and T S Gaginella
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 572-576;

  10. Wong, P C

    1. Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2).
      P C Wong, S D Hart, A M Zaspel, A T Chiu, R J Ardecky, R D Smith and P B Timmermans
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 584-592;

  11. Wong, W

    1. Genetically determined steady-state interaction between encainide and quinidine in patients with arrhythmias.
      J Turgeon, H N Pavlou, W Wong, C Funck-Brentano and D M Roden
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 642-649;

  12. Wozniak, D

    1. Influence of chronic alcohol administration on representative indices of puberty and sexual maturation in male rats and the development of their progeny.
      T J Cicero, M L Adams, L O'Connor, B Nock, E R Meyer and D Wozniak
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 707-715;

Y

  1. Yang, J

    1. Evaluation of cationized rat albumin as a potential blood-brain barrier drug transport vector.
      W M Pardridge, D Triguero, J Buciak and J Yang
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 893-899;

  2. Yum, S W

    1. Effects of TRH-analog treatment on tissue cations, phospholipids and energy metabolism after spinal cord injury.
      A I Faden, S W Yum, M Lemke and R Vink
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 608-614;

Z

  1. Zaspel, A M

    1. Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2).
      P C Wong, S D Hart, A M Zaspel, A T Chiu, R J Ardecky, R D Smith and P B Timmermans
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 584-592;

  2. Zavala, F

    1. In vivo treatment with benzodiazepines inhibits murine phagocyte oxidative metabolism and production of interleukin 1, tumor necrosis factor and interleukin-6.
      F Zavala, V Taupin and B Descamps-Latscha
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 442-450;

  3. Zemaitis, J M

    1. Effect of the leukotriene B4 receptor antagonist SC-41930 on colonic inflammation in rat, guinea pig and rabbit.
      D J Fretland, D Widomski, B S Tsai, J M Zemaitis, S Levin, S W Djuric, R L Shone and T S Gaginella
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 572-576;

  4. Ziegler, R J

    1. Neuromodulatory effects of atrial natriuretic factor are independent of guanylate cyclase in adrenergic neuronal pheochromocytoma cells.
      J G Drewett, R J Ziegler and G J Trachte
      Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 497-503;
Back to top

In this issue